The reintroduction of the bipartisan PASTEUR Act by the U.S. House of Representatives and the Senate is a critical step forward to address the antimicrobial resistance crisis that threatens the public health and U.S. national security and preparedness.
The Centers for Disease Control and Prevention took an important step today to clarify when and how often individuals should receive a booster shot of the COVID-19 vaccine.
Today’s ruling striking down the preventive services provision of the Affordable Care Act is a major setback to ending HIV as an epidemic and for improving the health of Americans by preventing the spread of other infectious diseases in the United States.
To better understand the challenges around recruitment, the Board of Directors dedicated its entire March meeting to a deep dive into the dynamics of the ID/HIV workforce.
Physicians who specialize in infectious diseases are an essential part of President Biden’s vision for seeking cancer cures and beating the opioid epidemic.
A U.S. Department of Health and Human Service COVID-19 Public Education Campaign to explain who is at increased risk for severe illness from COVID, the availability of COVID treatments, and the importance of early treatment.
IDSA is pleased to announce that Roger J. Bedimo, MD, FIDSA, has been selected as the next editor-in-chief of Open Forum Infectious Diseases. Dr. Bedimo will succeed interim co-editors-in-chief John Baddley, MD, MSPH, and Andrej Spec, MD, MSCI, FIDSA, who have led OFID throughout the search process.
IDSA welcomes the new editorial board members of The Journal of Infectious Diseases, who officially took office with Editor-in-Chief Cynthia L. Sears, MD, FIDSA, on Jan. 1.
The U.S. government’s new policy of requiring pre-flight COVID-19 testing for all travelers from China will likely have limited impact on transmission and will not provide the necessary data to fully assess the increasing number of cases globally.
IDSA applauds President Biden for signing the Consolidated Appropriations Act of 2023 into law. The law authorizes a loan repayment program that will help strengthen the infectious diseases workforce and provides needed funding to better prepare the nation for future pandemics – top priorities IDSA has been working with the Administration and Congress to address.
IDSA successfully led a significant advocacy effort to include the BIO Preparedness Workforce Pilot Program in PREVENT as part of a comprehensive effort to address the nation’s infectious diseases workforce shortage.
National poll reveals widespread support for measures to prepare America for future pandemics. Congress must take immediate action on the PREVENT Pandemics Act.